JP2019527361A5 - - Google Patents

Download PDF

Info

Publication number
JP2019527361A5
JP2019527361A5 JP2019503672A JP2019503672A JP2019527361A5 JP 2019527361 A5 JP2019527361 A5 JP 2019527361A5 JP 2019503672 A JP2019503672 A JP 2019503672A JP 2019503672 A JP2019503672 A JP 2019503672A JP 2019527361 A5 JP2019527361 A5 JP 2019527361A5
Authority
JP
Japan
Prior art keywords
patient
moieties
blood
free nucleosomes
extracellular free
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019503672A
Other languages
English (en)
Japanese (ja)
Other versions
JP6983221B2 (ja
JP2019527361A (ja
Filing date
Publication date
Priority claimed from GBGB1612815.9A external-priority patent/GB201612815D0/en
Application filed filed Critical
Publication of JP2019527361A publication Critical patent/JP2019527361A/ja
Publication of JP2019527361A5 publication Critical patent/JP2019527361A5/ja
Application granted granted Critical
Publication of JP6983221B2 publication Critical patent/JP6983221B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019503672A 2016-07-25 2017-07-25 大腸癌の併用検査 Active JP6983221B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1612815.9A GB201612815D0 (en) 2016-07-25 2016-07-25 Novel combination test
GB1612815.9 2016-07-25
PCT/EP2017/068754 WO2018019827A1 (en) 2016-07-25 2017-07-25 Combination test for colorectal cancer

Publications (3)

Publication Number Publication Date
JP2019527361A JP2019527361A (ja) 2019-09-26
JP2019527361A5 true JP2019527361A5 (https=) 2020-08-20
JP6983221B2 JP6983221B2 (ja) 2021-12-17

Family

ID=56894403

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019503672A Active JP6983221B2 (ja) 2016-07-25 2017-07-25 大腸癌の併用検査

Country Status (16)

Country Link
US (1) US20200182875A1 (https=)
EP (1) EP3488238B1 (https=)
JP (1) JP6983221B2 (https=)
KR (1) KR102442803B1 (https=)
CN (1) CN109791154A (https=)
AU (1) AU2017301970B2 (https=)
BR (1) BR112019001384A2 (https=)
CA (1) CA3031580A1 (https=)
GB (1) GB201612815D0 (https=)
IL (1) IL264359B2 (https=)
MY (1) MY193895A (https=)
RU (1) RU2019104870A (https=)
SG (2) SG10202100630SA (https=)
TW (1) TWI776816B (https=)
WO (1) WO2018019827A1 (https=)
ZA (1) ZA201808601B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201906199D0 (en) * 2019-05-02 2019-06-19 Belgian Volition Sprl Method for the detection of cancer
WO2021024009A1 (en) * 2019-08-02 2021-02-11 Shanghai Yunxiang Medical Technology Co., Ltd. Methods and compositions for providing colon cancer assessment using protein biomarkers
CN112345766B (zh) * 2020-10-22 2024-02-02 中国工程物理研究院核物理与化学研究所 一种荧光-放射性联用的体外靶向筛选方法
TW202242146A (zh) * 2021-01-13 2022-11-01 比利時商比利時意志有限公司 肺癌的檢測方法
EP4291899A1 (en) * 2021-02-11 2023-12-20 EDP Biotech Corporation Kits and methods for detecting markers and determining the presence or risk of cancer
WO2024223947A1 (en) * 2023-04-28 2024-10-31 Belgian Volition Srl Use of cell free nucleosomes as biomarkers of carcinomas
CN116973572B (zh) * 2023-06-02 2025-03-07 东南大学附属中大医院 基于血、粪便铁蛋白检测评估肠屏障损伤严重程度的方法
CN116718775B (zh) * 2023-08-04 2023-10-27 天津迈基生物科技有限公司 一种检测结直肠癌的组合物、试纸及方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2541178T3 (es) * 2009-02-03 2015-07-16 Mdxhealth Sa Método de detección de cáncer colorrectal
WO2010120942A2 (en) * 2009-04-14 2010-10-21 The Regents Of The University Of California Histone modification patterns for clinical diagnosis and prognosis of cancer
US8568984B2 (en) * 2010-02-19 2013-10-29 Philadelphia Health & Education Corporation Methods of diagnosing non-urinary tract diseases by detecting aberrant methylation
JP2012018119A (ja) * 2010-07-09 2012-01-26 Toray Ind Inc 大腸癌検出用マーカーおよびそれを用いた大腸癌検出方法
CN103328500B (zh) * 2010-08-04 2018-01-26 西兹尔生物技术有限公司 用于癌症的诊断和治疗的方法和化合物
GB201115098D0 (en) * 2011-09-01 2011-10-19 Belgian Volition Sa Method for detecting nucleosomes containing histone variants
PT2788767T (pt) * 2011-12-07 2017-12-06 Belgian Volition Sprl Método de detecção de adutos de nucleosoma
EP4001436B1 (en) * 2012-05-11 2024-03-13 Clinical Genomics Pty. Ltd. Diagnostic gene marker panel

Similar Documents

Publication Publication Date Title
JP2019527361A5 (https=)
Kaur et al. A comprehensive review
RU2019104870A (ru) Комбинированный тест на наличие колоректального рака
Bruhm et al. Genomic and fragmentomic landscapes of cell-free DNA for early cancer detection
Lamb et al. Epi proColon® 2.0 CE: a blood-based screening test for colorectal cancer
Bonne et al. Salivary biomarker development using genomic, proteomic and metabolomic approaches
Hanada et al. Effective screening for early diagnosis of pancreatic cancer
Kunavisarut Diagnostic biomarkers of differentiated thyroid cancer
Zhao et al. Levels of plasma Epstein-Barr virus DNA prior and subsequent to treatment predicts the prognosis of nasopharyngeal carcinoma
JP2009538607A5 (https=)
JP6941324B2 (ja) 新規な肝硬変または肝線維症のマーカー
Wong Salivary diagnostics
Montironi et al. Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist
JP2016500110A5 (https=)
Beretov et al. Proteomics for breast cancer urine biomarkers
Liu et al. Prognostic value of circulating tumor cells in advanced gastric cancer patients receiving chemotherapy
JP2018525994A5 (https=)
Altintas et al. Molecular biosensors: promising new tools for early detection of cancer
Wang et al. Human papillomavirus 16 infection and TP53 mutation: two distinct pathogeneses for oropharyngeal squamous cell carcinoma in an eastern chinese population
JP2015518152A (ja) 前立腺がんの検出用バイオマーカーの定量
Wang et al. Utility of circulating free DNA fragmentomics in the prediction of pathological response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer
Chen et al. Immunohistochemistry as a quick screening method for clinical detection of BRAF (V600E) mutation in melanoma patients
WO2022235718A3 (en) Compositions comprising nullomers and methods of using the same for cancer detection and diagnosis
Gu et al. A risk-scoring model for predicting lymph node metastasis in early gastric cancer patients: a retrospective study and external validation
Herold et al. Biosensors and molecular technologies for cancer diagnostics